Viewing StudyNCT00425256



Ignite Creation Date: 2024-05-05 @ 5:18 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00425256
Status: COMPLETED
Last Update Posted: 2011-02-23
First Post: 2007-01-18

Brief Title: Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder FSAD
Sponsor: Palatin Technologies Inc
Organization: Palatin Technologies Inc

Organization Data

Organization: Palatin Technologies Inc
Class: INDUSTRY
Study ID: PT-141-2005-53
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Palatin Technologies Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Robert Jordan
Old Organization: Palatin Technologies Inc

Collaborators

Name Class
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer INDUSTRY